资讯
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...
ATLANTA — Branson Blevins at just 11 years old is in the fight of his life, battling aggressive leukemia and undergoing a ...
All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...
Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...
Mar. 27, 2025 — Glucose is life's main energy source. But a new study reveals a surprising role as a master manipulator of tissue maturation, hinting at its importance in diabetes and ...
4 天
Money Talks News on MSNDoing This Just 3 Times a Year Might Lower Your Cancer RiskAnd donating blood three times per year could possibly save you, according to researchers at the Francis Crick Institute in ...
Bubbly and full of zeal, the Pomona resident remains positive despite facing his second battle with the disease. He expressed ...
Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...
Beerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products ...
Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果